{
    "clinical_study": {
        "@rank": "46929", 
        "arm_group": {
            "arm_group_label": "Transanal total mesorectal excision", 
            "arm_group_type": "Experimental", 
            "description": "Laparoscopy-assisted transanal total mesorectal excision"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is evaluation of the safety and the efficacy of transanal total\n      mesorectal excision."
        }, 
        "brief_title": "The Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision", 
        "completion_date": {
            "#text": "September 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Rectal Cancer", 
        "condition_browse": {
            "mesh_term": "Rectal Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Subjects will have their rectal cancer removed using a technique combining surgery through\n      the anus and standard laparoscopy. Transanal visualization will be using endoscopy.  At the\n      end of the procedure, the rectum will be removed though the anus or ileostomy formation\n      site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be\n      created, which is standard of care following surgery for this type of cancer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age: 20-80 years\n\n          -  biopsy-proven adenocarcinoma of the rectum\n\n          -  clinical staging, (T1 or T2 or T3) with N0M0\n\n          -  Rectal cancer located 4-12 cm from the anal verge\n\n          -  ECOG performance status 2 or less\n\n        Exclusion Criteria:\n\n          -  Synchronous colon cancer or other malignancy\n\n          -  Obstructing rectal cancer\n\n          -  Pregnant or breast-feeding\n\n          -  Receiving any other study agents\n\n          -  Fecal incontinence\n\n          -  History of prior colorectal cancer or inflammatory bowel disease\n\n          -  BMI > 30\n\n          -  T3 rectal cancer not treated preoperatively with full-course chemoradiation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01938027", 
            "org_study_id": "NCC-TAME", 
            "secondary_id": "NCC-1210170"
        }, 
        "intervention": {
            "arm_group_label": "Transanal total mesorectal excision", 
            "description": "Laparoscopy-assisted transanal total mesorectal excision", 
            "intervention_name": "Transanal total mesorectal excision", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Rectal Neoplasms", 
            "Colorectal Neoplasms"
        ], 
        "lastchanged_date": "September 10, 2013", 
        "location": {
            "contact": {
                "email": "jayoh@ncc.re.kr", 
                "last_name": "Jae Hwan Oh, MD,PHD", 
                "phone": "+82\u201031\u2010920\u20101637"
            }, 
            "contact_backup": {
                "email": "gsgsbal@ncc.re.kr", 
                "last_name": "Dae Kyung Sohn, MD,PHD", 
                "phone": "+82\u201031\u2010920\u20101636"
            }, 
            "facility": {
                "address": {
                    "city": "Goyang-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "410-769"
                }, 
                "name": "Jae Hwan Oh"
            }, 
            "investigator": {
                "last_name": "Jae Hwan Oh", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study for the Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision", 
        "other_outcome": {
            "measure": "Oncologic outcome(2-year local recurrence free survival, 5-year survival)", 
            "safety_issue": "Yes", 
            "time_frame": "1-5 years"
        }, 
        "overall_contact": {
            "email": "jayoh@ncc.re.kr", 
            "last_name": "Jae Hwan Oh, MD, PHD", 
            "phone": "+82\u201031\u2010920\u20101637"
        }, 
        "overall_contact_backup": {
            "email": "gsgsbal@ncc.re.kr", 
            "last_name": "Dae Kyung Sohn", 
            "phone": "+82\u201031\u2010920\u20101636"
        }, 
        "overall_official": {
            "affiliation": "NCC,Korea", 
            "last_name": "Jae Hwan Oh, MD, PHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: National Cancer Center", 
                "Korea: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The quality of the mesorectum was determined using pathology reports and scored using three grades:\nComplete: intact mesorectum with only minor irregularities of a smooth mesorectal surface. No defect is deeper than 5 mm, and there is no coning toward the distal margin of the specimen. There is a smooth circumferential resection margin on slicing.\nNearly complete: moderate bulk to the mesorectum, but irregularity of the mesorectal surface. Moderate coning of the specimen is allowed. At no site is the muscularis propria visible, with the exception of the insertion of the levator muscles.\nIncomplete: little bulk to mesorectum with defects down onto muscularis propria and/or very irregular circumferential resection margin.", 
            "measure": "Total Mesorectal Excision(TME) quality", 
            "safety_issue": "No", 
            "time_frame": "1-5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01938027"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Cancer Center, Korea", 
            "investigator_full_name": "Jae Hwan Oh", 
            "investigator_title": "Head of Center for Colorectal Cancer, National Cancer Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "30-day postoperative complications, No. of harvested LN", 
            "safety_issue": "Yes", 
            "time_frame": "1-5 years"
        }, 
        "source": "National Cancer Center, Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Center, Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}